Singapore state investment fund Temasek Holdings Private Ltd has increased its stake in NASDAQ-listed Regeneron Pharmaceuticals by 116.77 per cent, based on its latest Q1 2016 regulatory filing with the SEC, purchasing 68,062 shares as Regeneron’s stock declined 30.22 per cent while US stock markets rallied. The consideration for the enlarged stake is $24.5 million.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
